Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sequenom Earnings: Now There's an SEC Probe Into a Failed Hostile Bid, Too
BNET Pharma
Wednesday, March 17, 2010 - 10:28am
tags:
Sequenom, earnings, SEC, EXACT Sciences
Health-Care Bill Faces Delay as Democrats Struggle With CBO
Bloomberg
Wednesday, March 17, 2010 - 10:22am
tags:
healthcare bill, healthcare reform
Merck KGaA Issues Year’s Biggest Euro Company Bond to Fund Millipore
Bloomberg
Wednesday, March 17, 2010 - 10:21am
tags:
Merck KGaA, Millipore, M&A
Novartis China's Spectacular Climb in '09
Seeking Alpha
Wednesday, March 17, 2010 - 10:18am
tags:
Novartis, China
Pfizer Readies Bid for Ratiopharm: Report
TheStreet.com
Wednesday, March 17, 2010 - 10:16am
tags:
Ratiopharm, Pfizer, M&A
Dynavax hopes to submit Heplisav to FDA 6 months early
Bizjournals.com
Wednesday, March 17, 2010 - 9:41am
tags:
Dynavax, Heplisav, hepatitis B, Merck, vaccines, FDA
Wyeth Merger and Federal Legislation Pull Pfizer in Opposite Directions
Investor Guide
Tuesday, March 16, 2010 - 2:32pm
tags:
Wyeth, Pfizer, M&A
Pfizer-Ranbaxy: Could There Be Trouble Brewing?
Seeking Alpha
Tuesday, March 16, 2010 - 2:28pm
tags:
Pfizer, Ranbaxy, Schering Plough, Teva Pharmaceuticals
Big Drug Makers Said to Lag in Emerging Markets
NY Times, NY
Tuesday, March 16, 2010 - 11:02am
tags:
Big Pharma, emerging markets
Biotech VC funding leaps in 4Q as life sciences stays flat
Fierce Biotech
Tuesday, March 16, 2010 - 11:00am
tags:
venture capital, biotech
Merck to pay Dynavax $4M for Heplisav
Bizjournals.com
Tuesday, March 16, 2010 - 10:58am
tags:
Merck, Dynavax, Heplisav, hepatitis B
Biotech OSI Gathers All-Star Defense to Stiff-Arm a Hostile Takeover Bid
BNET Pharma
Tuesday, March 16, 2010 - 10:26am
tags:
OSI Pharmaceuticals, Astellas, M&A
The Next Botox?
CNBC
Tuesday, March 16, 2010 - 10:24am
tags:
Botox, Dysport, Allergan, Medicis
Ariad slips on news of Merck-deal revision
Bizjournals.com
Tuesday, March 16, 2010 - 10:23am
tags:
Ariad Pharmaceuticals, Merck, ridaforolimus
The scramble to save PhRMA's $80B deal
Fierce Pharma
Tuesday, March 16, 2010 - 10:22am
tags:
healthcare reform, PhRMA
3 Ways to Play the Obesity Drugs
TheStreet.com
Tuesday, March 16, 2010 - 10:05am
tags:
obesity, Arena Pharmaceuticals, Vivus, Orexigen, Contrave, Qnexa, lorcaserin
Hefty Allergan Sees Bullish Move
TheStreet.com
Tuesday, March 16, 2010 - 10:03am
tags:
Allergan
Bloodbath: SQNM Off 20%; No Financial Forecasts This Year, Looking for Cash
Barron's
Tuesday, March 16, 2010 - 10:01am
tags:
Sequenom
Sanofi-Aventis Pays $15M To Settle Discrimination Suit
Pharmalot
Tuesday, March 16, 2010 - 8:59am
tags:
discrimination, Sanofi, lawsuits
Novartis: No aliskiren benefit in heart attacks
Marketwatch
Tuesday, March 16, 2010 - 8:56am
tags:
Novartis, aliskiren, Tekturna

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.